Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure: A retrospective cohort study

International Journal of Medical Sciences

Volumn 10, Issue 12, 2013, Pages 1658-1664

  Zheng, Yu Bao ^a,b   Huang, Zhan Lian ^a,b   Wu, Zhe Bin ^a,b   Zhang, Min ^a,b   Gu, Yu Rong ^a,b   Su, Yu Jie ^a,b   Lin, Chao Shuang ^a,b   Zhu, Rui Hua ^a,b   Lin, Bin Liang ^a,b   Gao, Zhi Liang ^a,b  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Acute on chronic hepatitis b liver failure; And MELD score; Clinical features; Dynamic patterns; Prognosis

Indexed keywords

ADEFOVIR DIPIVOXIL; ALBUMIN; ANTIBIOTIC AGENT; ENTECAVIR; LACTULOSE; LAMIVUDINE; TELBIVUDINE; TERLIPRESSIN; VIRUS DNA;

ACUTE ON CHRONIC HEPATITIS B LIVER FAILURE; ADULT; ARTICLE; BACTERIAL PERITONITIS; BED REST; CHINA; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FLUID THERAPY; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

ACUTE-ON-CHRONIC HEPATITIS B LIVER FAILURE; AND MELD SCORE.; CLINICAL FEATURES; DYNAMIC PATTERNS; PROGNOSIS;

ADULT; CHINA; DISEASE PROGRESSION; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84884549775     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.6415     Document Type: Article

References (28)

1. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol. 2008; 6(12): 1315-1341.
2. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009; 49(5 Suppl): S45-55.
3. Garg H, Sarin SK, Kumar M, Garg V, Sharma BC, Kumar A. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology. 2011; 53(3): 774-780.
4. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33(2): 464-470.
5. Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009; 49(2): 646-657.
6. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007; 45(2): 507-539.
7. Novelli G, Rossi M, Ferretti G, Pugliese F, Ruberto F, Lai Q, et al. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system. Ther Apher Dial. 2009; 13(5): 404-412.
8. Li LJ, Yang Q, Huang JR, Xu XW, Chen YM, Fu SZ. Effect of artificial liver support system on patients with severe viral hepatitis: a study of four hundred cases. World J Gastroenterol. 2004; 10(20): 2984-2988.
9. Avolio AW, Nure E, Pompili M, Barbarino R, Basso M, Caccamo L, et al. Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches. Transplant Proc. 2008; 40(6): 1961-1964.
10. Bronsther O, Ersoz S, Tugcu M, Eghtesad B, Gurakar A, Van Thiel DH. Liver transplantation for HBV-related disease under immunosuppression with tacrolimus: an experience with 78 consecutive cases. J Okla State Med Assoc.1995; 88(3): 103-108.
11. Brown RS Jr., Russo MW, Lai M, Shiffman ML, Richardson MC, Everhart JE, et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med. 2003; 348(9): 818-825.
12. Ishigami M, Honda T, Okumura A, Ishikawa T, Kobayashi M, Katano Y, et al. Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation. J Gastroenterol. 2008; 43(5): 363-368.
13. Zheng YB, Xie DY, Gao ZL. Clinical features and dynamic patterns during clinical course of Acute-on-chronic hepatitis B liver failure can predict the prognosis of ACHBLF: a retrospective cohort study. Journal of hepatology. 2012; 56:S194.
14. Katoonizadeh A, Laleman W, Verslype C, Wilmer A, Maleux G, Roskams T, et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut. 2010; 59(11): 1561-1569.
15. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ. 2003; 326(7379): 41-44.
16. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2009; 3(1): 269-282.
17. Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007; 35(11): 2498-2508.
18. Liver Failure and Artificial Liver Group CMASLDaALG, Chinese Medical Association. [Diagnostic and treatment guidelines for liver failure]. Zhonghua Gan Zang Bing Za Zhi. 2006; 14(9): 643-646.
19. Zhang GL, Gao ZL. The immunological characteristics of and treatment strategies for HBV related acute-on-chronic liver failure. Chin J Viral Dis. 2011; 1(1): 5-8.
20. Zhang GL, Xie DY, Lin BL, Xie C, Ye YN, Peng L, et al. Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure. J Gastroenterol Hepatol. 2013; 28(3): 513-521.
21. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol. 2003; 38(4): 533-540.
22. Sun QF, Lu Y, Xu DZ, Lan XY, Liu JY, Sun XJ. [The impact of HBeAg positivity/negativity and HBV DNA loads on the prognosis of chronic severe hepatitis B]. Zhonghua Gan Zang Bing Za Zhi. 2006; 14(6): 410-413.
23. McCormick PA. Improving prognosis in hepatorenal syndrome. Gut. 2000; 47(2): 166-167.
24. Yang B, Wu YK, Chen ZC. The dynamic changes of AST, ALT, TBil and PT and their relationship with prognosis of acute-on-chronic hepatitis B liver failure. J Clini Hepatol. 2012; 28: 205-208.
25. Li YS, Kardorff R, Richter J, Sun KY, Zhou H, McManus DP, Hatz C. Ultrasound organometry: the importance of body height adjusted normal ranges in assessing liver and spleen parameters among Chinese subjects with Schistosoma japonicum infection. Acta Trop. 2004; 92(2): 133-138.
26. Zheng YB, Xie DY, Gu YR, Yan Y. Gao ZL, Ke WM, et al. Development of a sensitive prognostic scoring system for the evaluation of severity of acute-on-chronic hepatitis B liver failure: a retrospective cohort study. Clin Invest Med. 2012; 35(2): E75-85.
27. Duseja A, Chawla YK, Dhiman RK, Kumar A, Choudhary N, Taneja S. Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF). Dig Dis Sci. 2010; 55(11): 3188-3192.
28. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008; 48(2): 335-352.